Stay updated on Magrolimab vs. Venetoclax in TP53 AML Clinical Trial

Sign up to get notified when there's something new on the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Added the revision tag 'Revision: v3.5.5' and removed 'Revision: v3.5.4', signaling a minor update to the page's revision metadata.
    Difference
    0.0%
    Check dated 2026-06-02T22:44:25.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    A new document revision, Revision: v3.5.4, was added to the study record, replacing Revision: v3.5.3. This update indicates an updated version of the study protocol and related documentation.
    Difference
    0.0%
    Check dated 2026-05-19T12:31:01.000Z thumbnail image
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.5.3 was added and Revision: v3.5.2 was removed. This indicates a minor version update to the page rather than a change to the study details.
    Difference
    0.0%
    Check dated 2026-04-27T19:54:21.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Version bumped from 3.5.0 to 3.5.2.
    Difference
    0.0%
    Check dated 2026-04-20T15:46:40.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Naples, Italy, 80131 has been added as a study location and Napoli, Italy, 80131 removed; the study revision version updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T22:42:56.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-08T13:45:29.000Z thumbnail image

Stay in the know with updates to Magrolimab vs. Venetoclax in TP53 AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Magrolimab vs. Venetoclax in TP53 AML Clinical Trial page.